Takeda’s GI Biz Poised for Growth with 3 Products Now in Its Lineup

Koki Nakamura, GI Specialty Business Unit Head, Takeda Pharmaceutical With the NHI price listing of its Crohn’s disease cell therapy Alofisel (darvadstrocel) this month, Takeda Pharmaceutical now has three products in its gastrointestinal specialty franchise in Japan. The company is...read more